The combination of circulating Ang1 and Tie2 levels predicts progression-free survival advantage in bevacizumab-treated patients with ovarian cancer
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Alison Backen Rosamonde Elizabeth Banks Caroline Dive Gordon C. Jayson Amit M. Oza Carlo Berzuini |
| Publication date | June 19, 2014 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |